Honasa Consumer has received approval for the acquisition of Fluence Pharma, which offers condition-specific OTC supplement under the brand ‘Hair Fact, Skin Fact and Pro Fact’. The company will acquire majority 58% equity stake of Fluence Pharma via secondary purchase at Rs 135 crore enterprise value, subject to closing adjustments and completion of conditions precedent. The company will acquire remaining 42% equity stake of Fluence Pharma via secondary purchase in two tranches over the next 5-7 years from completion of acquisition of aforesaid stake.
This strategic acquisition marks Honasa's entry into the high-growth nutraceuticals space, reinforcing its commitment to building science-backed solutions that address evolving consumer needs across ‘inside-out’ beauty. Through this acquisition, Honasa Consumer will execute its entry into the category by establishing its dedicated subsidiary, Honasa Health. Under this new entity, the company will scale a highly differentiated B2C nutrition portfolio by combining Fluence’s patented clinical science and deep practitioner trust with its own expertise in brand building, consumer insights, and digital-first distribution. The board of directors of the company at its meeting held on June 23, 2026 approved the same.
Honasa Consumer, doing business as Mamaearth, provides e-commerce services. The company offers baby, skin, body, and hair care products, as well as mosquito protection roll on and creams.
